Guoxiang Jin

3.7k total citations
52 papers, 2.1k citations indexed

About

Guoxiang Jin is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Guoxiang Jin has authored 52 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cell Biology. Recurrent topics in Guoxiang Jin's work include Ubiquitin and proteasome pathways (10 papers), Cancer-related Molecular Pathways (5 papers) and Epigenetics and DNA Methylation (5 papers). Guoxiang Jin is often cited by papers focused on Ubiquitin and proteasome pathways (10 papers), Cancer-related Molecular Pathways (5 papers) and Epigenetics and DNA Methylation (5 papers). Guoxiang Jin collaborates with scholars based in China, Hong Kong and United States. Guoxiang Jin's co-authors include Hui‐Kuan Lin, Chien‐Feng Li, Zhongjun Zhou, Fei Han, Xian Zhang, Dazhi Xu, Chuan Xu, Zhen Cai, Chia‐Hsin Chan and Yuan Gao and has published in prestigious journals such as Cell, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Guoxiang Jin

48 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guoxiang Jin China 24 1.6k 523 457 258 205 52 2.1k
Y. Rebecca Chin United States 19 1.7k 1.1× 557 1.1× 340 0.7× 169 0.7× 291 1.4× 37 2.2k
David I. Bellovin United States 16 991 0.6× 553 1.1× 448 1.0× 143 0.6× 233 1.1× 30 1.8k
David R. Croucher Australia 24 1.3k 0.8× 507 1.0× 486 1.1× 135 0.5× 338 1.6× 47 2.1k
Baoqing Jia China 29 1.4k 0.9× 632 1.2× 731 1.6× 149 0.6× 236 1.2× 87 2.5k
Nilgun Tasdemir United States 15 1.1k 0.7× 429 0.8× 349 0.8× 153 0.6× 93 0.5× 26 1.6k
M. Phillip DeYoung United States 10 1.3k 0.9× 745 1.4× 435 1.0× 145 0.6× 224 1.1× 18 1.8k
Lori S. Hart United States 19 1.1k 0.7× 527 1.0× 404 0.9× 218 0.8× 356 1.7× 27 1.8k
Nikita Popov Germany 21 2.1k 1.4× 889 1.7× 387 0.8× 188 0.7× 355 1.7× 32 2.5k
Changcun Guo China 27 1.4k 0.9× 451 0.9× 582 1.3× 299 1.2× 94 0.5× 72 2.3k
Osvaldo Graña‐Castro Spain 29 2.2k 1.4× 618 1.2× 659 1.4× 338 1.3× 148 0.7× 61 3.2k

Countries citing papers authored by Guoxiang Jin

Since Specialization
Citations

This map shows the geographic impact of Guoxiang Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoxiang Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoxiang Jin more than expected).

Fields of papers citing papers by Guoxiang Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoxiang Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoxiang Jin. The network helps show where Guoxiang Jin may publish in the future.

Co-authorship network of co-authors of Guoxiang Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Guoxiang Jin. A scholar is included among the top collaborators of Guoxiang Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoxiang Jin. Guoxiang Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Jiang, Shaoshuai, Xinyi Liu, Yi He, et al.. (2024). Disorganized chromatin hierarchy and stem cell aging in a male patient of atypical laminopathy-based progeria mandibuloacral dysplasia type A. Nature Communications. 15(1). 10046–10046. 1 indexed citations
4.
Yang, Xi, et al.. (2024). MOF-mediated acetylation of UHRF1 enhances UHRF1 E3 ligase activity to facilitate DNA methylation maintenance. Cell Reports. 43(3). 113908–113908. 8 indexed citations
5.
Xie, Xiaoqing, Yi Yang, Qiang Wang, et al.. (2023). Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria. Cell Research. 33(3). 215–228. 66 indexed citations
6.
Gao, Ge, Xiaoping Li, Zhixin Jiang, et al.. (2023). Isthmin-1 (Ism1) modulates renal branching morphogenesis and mesenchyme condensation during early kidney development. Nature Communications. 14(1). 2378–2378. 3 indexed citations
7.
Zhang, Lian, et al.. (2023). RAGA prevents tumor immune evasion of LUAD by promoting CD47 lysosome degradation. Communications Biology. 6(1). 211–211. 7 indexed citations
8.
Zhang, Lian, Yujiao He, Yi Jiang, et al.. (2023). PRMT1 reverts the immune escape of necroptotic colon cancer through RIP3 methylation. Cell Death and Disease. 14(4). 233–233. 23 indexed citations
9.
He, Yi, Li Tuo, Fei Long, et al.. (2022). Rapid and robust derivation of mesenchymal stem cells from human pluripotent stem cells via temporal induction of neuralized ectoderm. Cell & Bioscience. 12(1). 31–31. 8 indexed citations
10.
Jin, Guoxiang, et al.. (2022). Post-Translational Modification of Lamins: Mechanisms and Functions. Frontiers in Cell and Developmental Biology. 10. 864191–864191. 23 indexed citations
11.
Zou, Hongbo, Anmei Zhang, Songtao Wang, et al.. (2019). MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway. Cell Death and Disease. 10(3). 148–148. 26 indexed citations
12.
Liu, Chunfang, Zhen Cai, Guoxiang Jin, et al.. (2018). Abnormal gametogenesis induced by p53 deficiency promotes tumor progression and drug resistance. Cell Discovery. 4(1). 54–54. 15 indexed citations
13.
Zhang, Xian, Chien‐Feng Li, Ling Zhang, et al.. (2016). TRAF6 Restricts p53 Mitochondrial Translocation, Apoptosis, and Tumor Suppression. Molecular Cell. 64(4). 803–814. 63 indexed citations
14.
Jin, Guoxiang, Szu-Wei Lee, Xian Zhang, et al.. (2015). Skp2-Mediated RagA Ubiquitination Elicits a Negative Feedback to Prevent Amino-Acid-Dependent mTORC1 Hyperactivation by Recruiting GATOR1. Molecular Cell. 58(6). 989–1000. 67 indexed citations
15.
Cui, Ju, Guoxiang Jin, Bin Yu, et al.. (2015). Stable knockdown of Kif5b in MDCK cells leads to epithelial–mesenchymal transition. Biochemical and Biophysical Research Communications. 463(1-2). 123–129. 2 indexed citations
16.
Jin, Guoxiang, Ying‐Jan Wang, & Hui‐Kuan Lin. (2013). Emerging Cellular Functions of Cytoplasmic PML. Frontiers in Oncology. 3. 147–147. 16 indexed citations
17.
Jin, Guoxiang. (2012). Flow characteristics of 42CrMo steel on unidirectional tension at different temperatures. Heat treatment of metals.
18.
Jin, Guoxiang, et al.. (2012). Stochastic resonance of a damped oscillator with frequency fluctuation driven by a periodic external force. Chinese Physics B. 21(12). 120502–120502. 13 indexed citations
19.
Chan, Kui Ming, Hoi Leong Xavier Wong, Guoxiang Jin, et al.. (2012). MT1-MMP Inactivates ADAM9 to Regulate FGFR2 Signaling and Calvarial Osteogenesis. Developmental Cell. 22(6). 1176–1190. 61 indexed citations
20.
Jin, Guoxiang, Fengju Zhang, Kui Ming Chan, et al.. (2011). MT1‐MMP cleaves Dll1 to negatively regulate Notch signalling to maintain normal B‐cell development. The EMBO Journal. 30(11). 2281–2293. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026